Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the effects of enoxaparin on venous
thromboembolism incidence and bleeding rate (major and minor bleeding) in patients undergoing
curative abdominal cancer surgery. The secondary objective is evaluate the incidence of
adverse events of enoxaparin in these patients.